Human cryptosporidiosis: a review.
OBJECTIVE
To provide an overview of risk factors, presentation and management of human cryptosporidium infection.


METHODS
Literature review was obtained through PubMed search.


METHODS
Published articles on the taxonomy of Cryptosporidium and the epidemiology, clinical presentation and management of cryptosporidiosis were reviewed.


METHODS
Abstracts and complete articles relevant to the objective were selected, read and analysed to extract information for this article.


CONCLUSIONS
Human cryptosporidiosis is a severe diarrhoeal disease in malnourished children and immuno-compromised adults in whom it confers poor prognosis. Management is mainly supportive as drug therapy remains elusive. Fortunately the prevalence in AIDS patients is declining due to the widespread use of combination antiretroviral therapy (cART).
Ayuo
P O
PO
P. O. Ayuo, MBChB, MMed, Senior Lecturer, Department of Medicine, School of Medicine, Moi University, P. O. Box 4606, Eldoret 30100, Kenya.
D000563:Amebicides / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000977:Antiparasitic Agents / Q000627:therapeutic use; D002965:Classification; D003049:Coccidiostats / Q000627:therapeutic use; D003457:Cryptosporidiosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000469:parasitology; D015658:HIV Infections; D006801:Humans; D007630:Kenya / Q000453:epidemiology; D009574:Nitro Compounds; D010303:Paromomycin / Q000627:therapeutic use; D011379:Prognosis; D015572:Spiramycin / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use
D000563:Amebicides; D000900:Anti-Bacterial Agents; D000977:Antiparasitic Agents; D003049:Coccidiostats; D009574:Nitro Compounds; D013844:Thiazoles; D010303:Paromomycin; D015572:Spiramycin; C041747:nitazoxanide